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Ethical and legal aspects of research involving older people with cognitive impairment: 
A survey of dementia researchers in Australia 
 
Abstract 
People with dementia are under-represented in clinical research, in part due to the ethical and 
legal complexities of involving people in studies who may lack capacity to consent. 
Excluding this population from research limits the evidence to inform care. The attitudes and 
practices of researchers are key to the inclusion of people with dementia in research, 
however, there are few empirical studies on researchers’ perspectives in this area. 
A cross-sectional study involved researchers in Australia who had experience in the ethical 
aspects of conducting dementia-related studies with human participants (n=70). Data were 
collected via an online survey from November 2017 to January 2018.  
Most respondents (97%) agreed with the importance of including people at all stages of 
dementia in research, yet around three-quarters of respondents perceived ethical and legal 
rules and processes as unduly restrictive or time-consuming. Researchers reported variable 
practices in assessing prospective participants’ capacity to consent to their studies. Various 
tools are used for this purpose, ranging from tools designed for research (eg, MacArthur 
Competence Assessment Tool for Clinical Research) to more general cognitive function 
screens (eg, Mini Mental State Exam).  
Few respondents (14%) routinely exclude people from studies who are unable to give their 
own consent, but instead seek permission from proxy decision-makers, such as legally 
appointed guardians or family carers. Respondents reported positive and negative outcomes 
of ethics review processes. Positive outcomes included strengthening the protections for 
3 
 
participants with cognitive impairment while negative outcomes included delays and 
inconsistent decisions from different ethics committees.  
The findings suggest a need for improved strategies in the research context to assess and 
enhance the decision-making capacity of people with dementia to support appropriate 
opportunities for inclusion. Education for ethics committees, proxy decision-makers and 
other gatekeepers is also needed to reduce barriers to participation in research.  






The population is ageing in many countries around the world, challenging health and aged 
care sectors to provide services for a growing number of older people with chronic illnesses, 
including dementia and other neurocognitive disorders (Prince et al., 2015). The strength of 
the evidence to inform care and supports for ageing populations is limited in part by the 
general underrepresentation of older people in clinical research (Watts, 2012; Whitham and 
Stott, 2017). The problem of exclusion from research is even more pernicious for older 
people living with dementia. People without the capacity to give their own consent to 
research have often been excluded from studies for ethical, legal and practical reasons, 
including worries about their vulnerability as research participants, the complexities of 
substitute decision-making in the research context, the risk of participant attrition, concerns 
about compliance with study protocols, and the need for study partners to help them take part 
in research activities (Rivett, 2017; Prusaczyk et al., 2017; West et al., 2017). 
Support for inclusion of people with dementia in research 
The harms and injustices of this exclusion from research are increasingly acknowledged, 
however, and inclusive research practices are now urged by dementia advocacy 
organisations, researchers across a range of disciplines, and governments faced with 
providing health services for ageing populations (Bartlett, Milne & Croucher, 2018; Gove et 
al., 2018; Phillipson and Hammond, 2018). In 2017, Alzheimer Europe announced in a 
position statement that it is “keen to promote the involvement of people with dementia in 
research” (Gove et al., 2018: 723). A 2018 report of a National Summit of the United States 
National Advisory Council on Alzheimer’s Research, Care and Services urges “research 
methods that will result in evidence-based programs and service” to benefit all persons living 
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with dementia (Gitlin & Maslow, 2018: 12). The UK Government (2015) aspires to more 
than double research participation among people diagnosed with dementia and Alzheimer’s 
Disease International (2018) calls for a doubling of global research output on dementia by 
2025. 
International ethical and legal frameworks emphasise the rights of people with disabilities to 
be supported to participate in society, including in research. The International Ethical 
Guidelines for Health-Related Research Involving Humans recognise the distinctive needs of 
people with conditions that impair cognition and urges their inclusion in research: “Adults 
who are not capable of giving informed consent must be included in health-related research 
unless a good scientific reason justifies their exclusion.” (Council for International 
Organizations of Medical Sciences, 2016: 61 [CIOMS]) The World Medical Association’s 
Declaration of Helsinki (2018: para 13) calls for historically underrepresented groups to have 
opportunities to take part in research.  
The United Nations Convention on the Rights of Persons with Disabilities (CRPD) (2006) 
emphasises the importance of autonomy for persons with disabilities, including the freedom 
to make their own choices and to enjoy full participation and inclusion in society (Article 3). 
At the same time, people with disabilities have the right not to be exploited and mistreated in 
the non-consensual conduct of medical and scientific experimentation (Article 15). Research 
ethics committees and those who support and care for older people with cognitive impairment 
have important roles in protecting the interests of those unable to give their own consent, 
however, they must also guard against decisions based on stereotypes and assumptions. Both 
the CRPD (Article 12) and the Declaration of Helsinki (World Medical Association, 2018: 
para 25) require that a person who is capable of making their own decisions be enabled to do 
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so and their decisions respected. Where a person with a disability lacks decisional capacity, 
substitute decision-makers should make choices that reflect the values and preferences of that 
person.  
Researchers’ views on involving people with dementia in research 
The attitudes and practices of researchers are key to supporting the appropriate inclusion of 
people with dementia in research, especially participants with reduced decision-making 
capacity, however, there is limited research on this topic. Prusaczyk et al. (2017: 8) recently 
pointed out that there is “a shortage of articles that explicitly state the challenges researchers 
have faced on this issue … [and] it is critical that common challenges and solutions are 
identified and reported in detail so that other studies can learn from and replicate successes.” 
Prior survey studies in the United States investigated consent practices among researchers in 
an Alzheimer’s disease clinical trials network (Karlawish et al., 2002), as well as dementia 
researchers’ views on how ethics rules affect study feasibility and protections for participants 
(Stocking et al., 2003). More recently, Black et al. (2014) conducted an ethnographic study of 
17 dementia researchers’ perceptions of study partners as well as a key informant study of 
assent and dissent practices in dementia research (Black et al., 2010). In Canada, Bravo et al. 
(2013) surveyed researchers in ageing about their practices in including participants with 
impaired decisional capacity and their knowledge of relevant law. Qualitative studies 
involving 13 dementia researchers in the Netherlands and 16 German and Israeli 
professionals in gerontology fields explored their attitudes toward advance directives for 
research (Jongsma and van de Vathorst, 2015; Werner and Schicktanz, 2018). To our 
knowledge, the only other study involving researchers from Australia was a joint Australia-
US project that surveyed 157 researchers across both countries about their experiences of 
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seeking ethics review of studies involving older adults (Pachana et al., 2015). Respondents 
included academic researchers, undergraduate and postgraduate research students, and 
clinician-researchers. To add to this scant literature, we undertook a cross-sectional national 
survey of researchers in Australia with experience in conducting dementia-related studies 
with human participants.  
 
Aims 
The study investigated researchers’: 
1) perceptions of the importance of involving people at varying stages of dementia in 
research, and barriers to such research; 
2) practices in determining the capacity of a person with dementia to consent to research and 
in seeking consent from substitute decision-makers where necessary; and 
3) experiences with ethics committees when seeking approval for studies involving people 
with dementia who have fluctuating or reduced capacity.  
 
Method 
Participant eligibility criteria  
Researchers were eligible if they conducted research in Australia and had direct experience in 
the ethical aspects of conducting dementia-related studies with human participants, for 
example, handling ethics review processes, recruiting participants, assessing capacity to 
consent, and seeking consent from substitute decision-makers. An initial survey question 
confirmed eligibility and respondents who reported they did not have relevant experience 
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exited the survey. 
Recruitment and data collection  
Eligible researchers were identified from publicly available announcements of dementia grant 
recipients from major Australian funding bodies, the National Health and Medical Research 
Council, the Dementia Collaborative Research Centres and the Dementia Australia Research 
Foundation. Researchers’ institutional website profiles and publication lists were reviewed to 
confirm whether they met the eligibility criteria. Research collaborators of funding recipients 
who met the study inclusion criteria were also invited to participate. The lead author 
(INITIALS BLINDED) contacted eligible researchers using their publicly available email 
with an invitation to complete the online survey. Two reminder emails were sent after three 
and eight weeks of non-response from the date of initial contact. Commencement of the 
survey was taken as implied consent. Survey responses were received from November 2017 
to the end of January 2018.  
Measures 
The survey consisted of questions with Likert rating scales as well as multiple choice 
response options. For some questions, optional open-ended text boxes were used to collect 
qualitative data. The survey instrument was developed based on a thorough review of 
literature on the ethical aspects of including people with dementia in health-related research, 
as well as ethics guidelines and legal requirements for research involving people who may 
lack decisional capacity. The initial survey instrument was reviewed by approximately 10 
researchers experienced in conducting dementia studies with human participants to ensure all 




Perceived importance of and barriers to involving people with dementia in research. 
Respondents were asked how important it is to include people with varying stages of 
dementia in research (very, somewhat, not at all important). They were then asked to rate 
their level of concern in relation to six ethical, legal and practical barriers to involving people 
with dementia in research who have fluctuating or reduced capacity (very, somewhat, not at 
all concerned; see Table 2). They could add other concerns in a text box. 
Practices in determining capacity to consent to research and seeking consent from substitute 
decision-makers.  
Respondents were asked how often they exclude people with dementia who are unable to 
give their own consent to participate in a study (always, very often, sometimes, rarely, never). 
They were asked if they had ever sought consent from another person or entity to include a 
person with dementia in a study (yes, no, don’t recall). If yes, they were asked how often they 
sought consent from each of the following: a legal body, such as a guardianship tribunal or 
court; an individual with formal authority to make decisions for the person, such as an 
enduring guardian for health decisions; or an individual with informal authority, such as a 
family carer (always, very often, sometimes, rarely, never). They could specify in a text box 
any other decision-makers from whom they had sought consent. 
 
These respondents were also asked how often in their research the following were involved in 
determining whether a person with dementia has capacity to consent to a study: a health 
professional external to the research team, such as the prospective participant’s doctor; a 
member of the research team; or a legal body, such as a guardianship tribunal (always, very 
often, sometimes, rarely, never). They could specify in a text box anyone else involved in 
determining capacity to consent. Respondents were asked if a specific tool or questionnaire 
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was used to assess capacity to consent to research for participants in their studies (yes, no, 
don’t know) and, if yes, to specify the tool(s).  
 
Experiences with research ethics committees  
Respondents were asked whether they had experience of seeking approval from an ethics 
committee to involve people with dementia in research where participants had fluctuating or 
reduced capacity (yes, no). If yes, they were asked about both the positive and negative 
consequences of the ethics review process (eg, improved protections for research participants; 
guidance in planning for future research; excessive delay in commencing research, with self-
report of the length of delay; inconsistent responses from different ethics committees to the 
same study protocol). They were also asked about matters that required considerable 
discussion with the committee to obtain study approval (eg, recruitment and consent 
processes). ‘Considerable discussion’ was defined as meaning more than two rounds of 
feedback were provided by the committee about the issue and/or more than one hour of 
conversation was required to resolve the issue. The survey questions about positive and 
negative consequences and matters requiring considerable discussion were adapted from a 
survey instrument reported by Edwards et al. (2011). For these questions, respondents were 
asked to select all applicable options and could specify additional issues in a text box. 
 
Demographic items 
Respondents were asked to indicate: years of experience conducting research involving 
human participants, as well as years of research experience specifically conducting research 
with people with dementia; the population focus of their research (people with dementia 
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living in the community, in institutional settings such as a care facility, or a mix of both); 
whether they have involved people with dementia as co-researchers to assist with study 
design, data collection, data analysis, or other research activities; discipline of research; 
whether they have served on a human research ethics committee and, if yes, their years of 




Survey responses are reported using descriptive statistics, including frequencies and 
percentages for each variable of interest. Fifteen participants did not complete the full survey, 
but were included in the analysis for each aim where they had complete data. Quotations 
from comments made in text boxes are included to illustrate respondents’ additional concerns 
and experiences beyond the quantitative data.  
 
Results 
Response rate and sample characteristics 
The survey was sent to 135 eligible researchers and 70 usable surveys were returned for a 
response rate of 52%. The survey respondents represent an experienced sample of researchers 
in a range of disciplines from all states and territories in Australia, with a majority working in 
the most populous states of New South Wales (50%) and Victoria (21%). Table 1 reports key 
demographic characteristics. 
< Insert Table 1 about here > 
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Perceived importance of and barriers to involving people with dementia in research 
Nearly all respondents (97%, n=68) stated it is very (74%, n=52) or somewhat important 
(23%, n=16) to include people at varying stages of dementia in studies. Yet, as reported in 
Table 2, many respondents expressed concern about barriers to research inclusion for people 
with dementia who have fluctuating or reduced decision-making capacity. 
< Insert Table 2 about here > 
 
Practices in determining capacity to consent to research and seeking consent from 
substitute decision-makers 
When asked how often they exclude people with dementia who are unable to give their own 
consent, just 14% (n=10) of researchers reported they always or very often use this exclusion 
criterion, 36% (n=25) said sometimes, while 49% (n=34) responded rarely or never. 
Consequently, most respondents (80%, n=56) reported they had experience in seeking 
consent from another person or entity to include a person with dementia in a study. These 
respondents were asked about who is involved in assessing capacity to consent, and the 
people who most frequently act as substitute decision makers for people with reduced 
decisional capacity (Table 3).  
Determining capacity to consent to research  
In relation to their research studies, the respondents reported variation in how and by whom a 
prospective participant’s decision-making capacity is assessed (Table 3). A majority of 
respondents (59%, n=33) said a research team member is very often or always involved in 
determining whether a person with dementia has capacity to consent to a study and 38% 
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(n=21) stated that an external health professional is very often or always involved. A minority 
(16%, n=9) said a legal body is sometimes involved in capacity determinations. Family 
members, informal carers and aged care facility staff were noted as other people who are 
sometimes involved in determining capacity to consent.  
Just over one third of respondents (36%, n=20) reported that a specific tool was used to 
assess the capacity to consent of participants in their studies. These varied from tools specific 
to research participation, such as the Evaluation to Sign Consent (Resnick et al., 2007) and 
the MacArthur Competence Assessment Tool for Clinical Research (MacCAT-CR) 
(Appelbaum & Grisso, 2001) to more general cognitive function screens, such as the Mini 
Mental State Exam (MMSE). Other tools noted were the Rowland Universal Dementia 
Assessment Scale (RUDAS), the Montreal Cognitive Assessment (MoCA), Psychogeriatric 
Assessment Scales (PAS), Geriatric Dementia Rating Scale (GDRS), Functional Assessment 
Staging of Alzheimer’s Disease (FAST) and the General Practitioner Assessment of 
Cognition (GPCOG). 
Seeking consent from substitute decision-makers 
Of researchers who indicated they had experience in seeking consent from another person, a 
majority (60%, n=34) reported they very often or always seek consent from an individual 
with formal legal authority to make decisions on behalf of the person with dementia, such as 
a legally appointed enduring guardian. About half of the respondents (51%, n=29) reported 
they very often or always seek consent from an individual with informal responsibility, such 
as a family member or carer. Few respondents had applied to a tribunal or court for approval 
to include a person with impaired capacity in a study. About 20% (n=11) reported they had 
approached others for permission to include a person with dementia in a study, including the 
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person’s general medical practitioner or specialist, or a senior staff member of an aged care 
facility. Some respondents referred to this as seeking ‘assent’ for the older person’s 
participation.  
< Insert Table 3 about here >   
 
Experiences with research ethics committees 
Nearly 70% of the survey respondents (n=48) said they had experience of seeking approval 
from an ethics committee to involve people with dementia in research where the participants 
had fluctuating or reduced capacity.  
Positive and negative consequences of the review process 
These respondents reported both positive and negative outcomes of the ethics review process. 
Positive outcomes included strengthening the protections for participants with cognitive 
impairment and helping researchers plan for future research involving this population. Half of 
respondents (n=24) reported they had received inconsistent outcomes from different 
committees, for example, in multi-site studies. Almost 30 per cent (n=14) felt that ethics 
review processes had caused excessive delays, reported as ranging from six to 18 months. In 
a few cases, respondents commented that approval delays resulted in the abandonment of 
proposed studies, including by doctoral research candidates.  
< Insert Table 4 about here > 
Issues requiring considerable discussion 
Half of respondents (n=24) reported considerable discussion about the process for seeking 
consent for participants with cognitive impairment to take part in their studies. A quarter to a 
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third of respondents reported considerable discussion about processes for: approaching or 
inviting potential participants (33%, n=16); seeking consent from a substitute decision maker 
(29%, n=14); and assessing the decision-making capacity of the person with cognitive 
impairment (25%, n=12). 
Comments about ethics committees and other gatekeepers 
Respondents cited the importance of improving the understanding of dementia among ethics 
committee members: “Most Ethics committees consider any person with dementia, at any 
stage of the disease as ‘vulnerable’ and unable to make a decision about participation.”  
“Lack of understanding of ethics committees and researchers about the use of inclusive 
research approaches contributes to barriers. As do expectations that people with dementia 
should have to fit into standard research designs.” Another respondent criticised pro forma 
recruitment documents expected by ethics committees: “The templates used as research 
information sheets and consent forms are completely inadequate to support someone with 
dementia [to] make an informed decision.” 
Beyond the formal gatekeeping role of ethics committees, the survey respondents identified 
that family members, clinicians and care facility staff are informal gatekeepers who can help 
or hinder research inclusion. Similar to comments about ethics committees, one survey 
respondent remarked that these gatekeepers “bring certain beliefs or assumptions about the 
person’s capacity, which can derail attempts to approach them” to discuss research 
opportunities and assess decisional capacity. Another researcher observed that “clinicians and 
carers may also act as gatekeepers if they have different views on the benefits of participation 
for the person with dementia.” They may assume the person with dementia would not be 
interested in or capable of being part of a study: “I think we miss a vital voice within the 
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research if there are institutional processes which makes it hard to include people living with 
dementia. There also seem to be layers of informal ‘gatekeepers’ who think people wouldn’t 
want to participate in particular kinds of research.” Another researcher stressed the need to 
address “[s]tigmatisation which assumes people living with dementia are not able to 
participate.” 
 
Involving people with dementia as co-researchers 
Our survey focused on researchers’ views and experiences in relation to involving people 
with dementia as participants in studies. However, we included a demographic question 
asking whether respondents had experience involving people with dementia as co-
researchers, such as to assist with study design, data collection, data analysis or other 
research activities. A sizeable minority (41%) reported they had this experience and several 
qualitative comments alluded to the benefit of this involvement: “earlier consumer input 
[helps] us articulate the importance of the research and structure the design to be consumer 
focused.” In turn, it was suggested that the need for back and forth discussion with ethics 
committees on recruitment and consent processes can be reduced if the protocol is developed 
with input from consumers.  
Discussion 
Inclusion is important but barriers persist 
While almost all of our survey respondents agreed with the importance of including people 
with dementia in research, a majority – around three-quarters and above – reported concerns 
with ethical, legal and practical barriers. A previous US-Australia survey concluded that 
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many researchers are nervous about including people with cognitive impairment in research 
(Pachana et al., 2015) and other researchers offer autoethnographic accounts of barriers they 
have encountered (Cubit, 2010; Monroe et al., 2013). The dominant concerns for our 
respondents were about recruitment and retention, which highlights the need for strategies 
that advance the responsible research goals of ensuring that people with dementia are aware 
of research opportunities and that study processes are tailored to overcome participation 
barriers for people with dementia and their study partners (Bartlett et al., 2018).  
Many respondents perceived ethical and legal rules and ethics review processes as unduly 
restrictive or time-consuming. Australia has a National Statement on the Ethical Conduct of 
Human Research that provides a nationally consistent ethics framework, however, each state 
and territory has its own laws governing health-related decision-making for people who lack 
capacity. An analysis of relevant laws argued that “this wide legislative variation has no 
rational foundation, precludes a consistent approach to research governance and participation, 
and hinders research that seeks to include people with impaired capacity, especially multi-
jurisdictional studies.” (Ries, Thompson & Lowe, 2017: 361) We comment further below on 
improving consent processes and the benefits of clear legal rules to guide decision-making 
when a prospective participant cannot give their own consent.  
 
Determining capacity to consent to research 
Capacity is decision and time-specific (Werner & Schicktanz, 2017) and dementia must not 
be equated with an assumption of global incapacity (Palmer et al., 2017). To respect 
autonomy, consent for research participation must be sought from the prospective participant 
if they are capable of making their own choice on the matter. Our results indicate there is no 
18 
 
clear and consistent approach for assessing decision-making capacity for research studies. 
While researchers are often involved in these determinations, respondents reported a variety 
of approaches to assessing capacity, including use of the MMSE and other tools not specific 
to the research context. Variation in approaches to assessing consent was also reported among 
Canadian researchers conducting ageing-related studies (Bravo et al., 2013). Just under 30% 
of researchers in that survey (28.6%) reported using a specific capacity assessment tool, with 
the MMSE most commonly cited.  
These findings suggest a need for improving awareness among researchers of appropriate 
strategies to assess decisional capacity specific to the research context. Capacity assessment 
processes should explore the prospective participant’s understanding of concepts related to 
research, as well as the requirements, benefits and risks of taking part in a particular study. A 
MMSE score may be useful in identifying prospective participants with potentially reduced 
capacity, but should not on its own rule people in or out of opportunities to take part in 
studies. One quarter to one half of people who are rated as moderately cognitively impaired 
(MMSE score of 12-19) may nonetheless be able to make a choice about taking part in a 
study (Whelan et al., 2009; Guarino et al., 2016). Moreover, around 15% of those judged to 
have milder impairment (MMSE 20-26) may lack decisional capacity in regard to clinical 
trial participation (Guarino et al., 2016). Palmer et al. (2017) reported that nearly a third of 
people with mild to moderate Alzheimer’s disease had capacity to consent to research in the 
context of medium risk (drug trial) and higher risk (immunotherapy trial) protocols. 
Various tools have been developed to assess capacity to consent in the research context, 
including six tools that have been evaluated in older adults with cognitive impairment 
(Gilbert et al., 2017). The MacCAT-CR is supported by the most empirical research 
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(Appelbaum & Grisso, 2001), however it takes around 20 minutes to administer and requires 
special training. The 10-item UCSD Brief Assessment of Consent Capacity (UBACC) (Jeste 
et al., 2007; Seaman et al., 2015) shows promise for use in dementia research. Guarino et al. 
(2016) recently described the value of an informed consent questionnaire designed to assess 
prospective participants’ understanding of a specific study as well as their rights as research 
participants. In general, Palmer et al. (2017: 31) recommend that “at minimum, a structured 
assessment of the ability to describe, in the participant’s own words, the purpose, procedures, 
and potential risks of the research, should be conducted for each trial.” Researchers may need 
to educate gatekeepers, such as aged care facility managers or medical practitioners, on the 
importance of study-specific consent discussions to ensure that potentially eligible and 
interested participants are not excluded based on assumptions of incapacity (Goodman et al., 
2011). 
Lengthy information sheets and consent forms were criticised by some of our respondents as 
poor ways to communicate with people with dementia. This critique applies with even more 
force for people with neurocognitive disorders who also have limited formal education. 
Palmer et al. (2017) found that a diagnosis of Alzheimer’s disease, combined with lower 
educational attainment and poor health and research literacy, was associated with a lack of 
capacity to consent to a study. Communication strategies suited to the needs of people with 
dementia (Eggenberger, Heimerl & Bennett, 2013) can enhance their understanding and 
decision-making about taking part in research and help to overcome these barriers. Once 
involved in a study, process consent can be used for ongoing checks of the participant’s 




The role of substitute decision-makers  
An important finding of our survey is that many dementia researchers do not automatically 
exclude a person who is unable to give their own consent, but instead seek consent from 
substitute decision-makers, such as a formally appointed guardian or a family carer. Research 
ethics rules typically require the consent of a legally authorised representative when the 
prospective participant is unable to give their own consent. However, legislation may not 
clearly specify who has this legal authority or it may not permit a person’s healthcare 
decision-maker to consent to experimental research interventions (Ries, Thompson & Lowe, 
2017). Our study showed that researchers often seek substitute consent from family members, 
yet the legal authority for this consent may be unclear. Our survey did not test respondents’ 
knowledge of the law, a limitation we note below, however a Canadian study found that just 
over one quarter (28%) of researchers had a correct understanding of the law and many 
assumed that family members had legal authority to give consent to research participation 
(Bravo et al., 2013).  
Laws should provide clear rules on who can consent to research participation for a person 
who lacks capacity to make their own choices (Thorogood et al., 2018), for example, by 
recognising a Power of Attorney for Research (Heesters et al., 2017; Davis, 2017). 
Researchers also need simple and accessible resources to help them understand and follow 
legal requirements. These measures should be complemented by strategies to support 
substitute decision-makers in understanding and carrying out their role in the research 
context. For example, where a substitute decision-maker is approached, researchers should 
ensure that study consent materials clearly explain their decision-making role, in line with 
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any relevant legal rules in the study jurisdiction, such as a statutory obligation to make a 
decision that reflects the known values and preferences of the person with impaired capacity.  
 
Research ethics committees and other gatekeepers 
Our results add to the findings of a previous US-Australia survey in which researchers 
expressed concern about ethics committees holding “overly protective and potentially 
patronizing or ageist” assumptions about older people and those with conditions affecting 
cognition (Pachana et al., 2015: 704). Researchers in that study felt an onus to educate 
committees about older adults and inclusive research approaches and described a “big 
learning curve” to surmount (Pachana et al., 2015: 703). Our findings revealed that the 
proposed processes for seeking consent from a person with cognitive impairment commonly 
require considerable discussions between researchers and ethics committees. This finding 
may reflect committee members’ inaccurate assumptions about dementia that could be 
addressed through education. However, the absence of consistent, widely accepted processes 
for assessing capacity to consent to research likely also contributes to the need for discussion, 
delays and changes to study protocols. At the same time, dialogue with ethics committees can 
improve protections for participants with cognitive impairment, as reported by nearly 40% of 
our respondents. 
Half of our respondents reported receiving inconsistent outcomes from different ethics 
committees. In Australia, a majority of states and territories participate in a National Mutual 
Acceptance scheme for the ethical and scientific review of some multi-site studies, however 
investigators must ensure their research protocols comply with laws in their jurisdiction, 
which may impose differing rules on matters such as consent, substitute decision-making and 
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data collection (National Health and Medical Research Council, 2018a). Ambitious proposals 
to streamline ethics review processes are being advocated elsewhere, such as regulatory 
changes in North America to provide a single review committee for multi-site clinical trials 
on neurodegenerative diseases (Knopman et al., 2017; Gauthier, Robillard and de Champlain, 
2018).  
Respondents also commented on ‘gatekeepers’ aside from ethics committees, including 
family members, clinicians and care facility staff, with whom researchers must collaborate to 
involve people with dementia in studies. These findings add to accounts from dementia 
researchers in other countries about the power of gatekeepers (Brooks, Savitch & Gridley, 
2017; Holland & Kydd, 2015) and the importance of effective engagement with study 
partners (Largent, Karlawish & Grill, 2018; Black et al., 2018) and clinicians (Manthorpe et 
al., 2013) who support and care for people with dementia. Researchers must address their 
concerns about the burdens of research activities and provide practical supports for inclusive 
approaches (Bartlett et al., 2018). Doing so can have multiple benefits. For example, if a 
member of the research team is responsible for conducting a study-specific assessment of a 
person’s capacity to consent, this will reduce the burden on clinicians to determine capacity.   
 
Future research 
Where a person with dementia has the requisite decisional capacity, they may wish to engage 
in advance research planning to reflect on, discuss and document their preferences for being 
involved in study activities during future periods of incapacity (Pierce, 2010; Porteri, 2018). 
This strategy would provide evidence of the person’s values and wishes to guide substitute 
decision-makers, researchers and ethics committees. This form of planning has support in 
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some research ethics guidelines. Australia’s National Ethics Statement encourages 
researchers, at the time of recruitment, to discuss and document future preferences with 
participants, especially if cognitive decline over the course of the study is anticipated 
(National Health and Medical Research Council, 2018b: para 4.5.7). The International 
Ethical Guidelines for Health-Related Research Involving Humans states that valid advance 
research directives should be respected (CIOMS, 2016: 61). A Canadian randomised 
controlled trial of an advance research planning intervention resulted in 80% of older adult 
participants documenting their preferences for future research participation (Bravo et al., 
2016). Further studies are needed to investigate the feasibility, acceptability and effectiveness 
of advance research planning for the various stakeholders involved. 
Strategies for enhancing and supporting decision-making about research participation by 
people with dementia is a key area for future investigation. Supported decision-making as 
envisioned by the UN CRPD and some domestic laws (Keeling, 2016; Then et al., 2018) puts 
new responsibilities on family members, study partners and researchers to adopt inclusive 
practices that enable people living with cognitive impairment to make their own choices, 
including about taking part in research. To date, there is little practical guidance in this 
context. A European research project currently underway aims to provide recommendations 
for supported decision-making and capacity assessment in clinical dementia research 
(Haberstroh, Oswald & Pantel, 2017; Vollmann, Gather & Scholten, 2017). Tools to help 
prospective participants understand and make choices about a study are also needed. Memory 
aids with simple and plain language information about an early phase clinical trial enhanced 
the ability of people with mild to early moderate Alzheimer’s disease to make their own 
decisions (Rubright et al., 2010). In contrast, a recent study with a similar population found 
that multi-media tools, including video clips and animations, did not enhance decision-
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making capacity (Palmer et al., 2018). The investigators suggested that multimedia tools may 
be inadequate to overcome the rapid forgetting experienced by some people with dementia 
and recommend further work on memory aids as well as supported decision-making 
processes in the research recruitment context.  
Other recent work has focused on innovative strategies to support qualitative research 
involving people with dementia (Novek & Wilkinson, 2017), including the use of arts-based 
and visual methods such as photography and videorecording (Phillipson & Hammond, 2018) 
and participatory action research to promote culture changes in community and institutional 
care settings (Mann & Hung, 2018). A pan-European consultation recently sought the views 
of people with dementia on meaningful outcomes for psychosocial interventions (Øksnebjerg 
et al., 2018). These initiatives offer valuable contributions to inclusive research practices, but 
acknowledge that they have focused on people with mild to moderate symptoms and barriers 
persist in involving people with more advanced dementia in research. Resonant with our 
findings, this literature underscores the challenges in using innovative methods, including 
“complexities…around recruitment, ethics and consent processes…complicated and rigid 
ethics processes and from a funding perspective, a lack of acknowledgment of the time 
required to build and participate in meaningful research interactions involving people with 
dementia” (Phillipson & Hammond, 2018: 11). Moreover, further work is needed on optimal 
strategies for involving carers as study partners, especially to strike an “appropriate balance 
between carers supporting people with dementia to have a voice, and carers speaking for the 




Several recent reviews discuss the merits and challenges of co-research in aging-related 
research (Schilling & Gerhardus, 2017), including with older people living with dementia (Di 
Lorito et al., 2017; Stevenson & Taylor, 2019) and emphasise the need for further work in 
this area. Strategies to assist researchers in appropriately including people with impaired 
cognition as participants can also inform their involvement as co-researchers (Rivett, 2017). 
More published accounts are needed that offer the forthright views of all the parties in co-
research relationships (Littlechild, Tanner & Hall, 2015) on key issues such as ensuring 
inclusive and meaningful collaborations (Bindels et al., 2014), methodological rigour (Buffel, 
2018), especially in more complex study designs (Heaven et al., 2016), and planning for the 
role of co-researchers experiencing progressive cognitive decline (Iliffe, McGrath & 
Mitchell, 2013). Funding for dementia research should take into account the support needed 
to effectively involve people with dementia as co-researchers.  
 
Limitations 
The survey did not test researchers’ knowledge of the law in their jurisdiction, for example, 
to determine if researchers seek consent from the legally appropriate decision-maker. 
Previous American and Canadian studies show that consent practices may not follow legal 
requirements, suggesting the need for legal educational resources tailored for researchers 
(Karlawish et al., 2002; Bravo et al., 2013). The majority of our sample was female (64% of 
researchers contacted and 71% of respondents), similar to Pachana et al.’s (2015) survey of 
Australian and American ageing researchers where 73% of respondents were women. We 
have highlighted some points of agreement and difference between our findings and other 
empirical studies of researchers in Canada, the US and the Netherlands; cultural and legal 
26 
 
differences in other countries may reveal different attitudes and experiences among 
researchers. For example, Werner and Schicktanz (2018) recently considered how differing 
legal frameworks influence the views of researchers in Germany and Israel on advance 
directives for dementia research. Our survey instrument used fixed choice questions and 
provided space for respondents to add comments in text boxes. While many of them did so, 
this technique does not allow for in-depth exploration of attitudes and experiences. A follow-




There is burgeoning international attention to the need for inclusive research practices that 
provide appropriate opportunities for people at risk of or living with dementia to be involved 
in studies. Researchers are key stakeholders in this transformative project. Our survey of 
dementia researchers in Australia provides insights on current practices and experiences 
related to the ethical, legal and practical complexities of involving participants who may lack 
capacity to consent. These findings can inform strategies and future research in relation to 
practices for assessing and enhancing consent and the role of research decision-makers and 
gatekeepers. Further empirical investigations in these areas are needed and should 
complement broader strategies to increase community awareness of dementia research and to 
enable meaningful patient and public involvement in research. 
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Table 1: Demographic characteristics  
Characteristic Response % (n) 
Years of research experience (n=58) 
1-7 years 
8-15 years 




Years of experience conducting research with 
people with dementia (n=58) 
1-7 years 
8-15 years 




Population focus of research (n=63) 
People with dementia in community 
settings 
29% (18) 
People with dementia in 
institutional settings 
16% (10) 
Mix of both 56% (35) 
























 *Other areas specified were health services research, 
palliative care, pharmacy, social sciences and arts. 






Gender (n=58) Female 
Male 




Demographic questions were divided between the start and end of the survey; complete demographic data is not 
available for respondents who did not finish the survey. Percentages are calculated based on number of responses 
available for each question.    
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Table 2: Perceived barriers to inclusion of people with dementia in research (n=70) 
Barriers of concern to dementia researchers                            % (n) very /somewhat concerned 
Difficult or time consuming to recruit such participants  84% (59) 
Difficult to retain such participants in a study over time 80% (56) 
Ethics rules unduly restrict participation by people with fluctuating or reduced capacity 80% (56) 
Legal rules unduly restrict participation by people with fluctuating or reduced capacity 74% (52) 
Difficult or time consuming to get ethics approval 74% (52) 





Table 3: Who is involved in determining capacity and giving substitute consent (n=56) 
In your research, how often are the following involved in determining if a person with dementia has 
capacity to consent to a research study? % (n) 
 Always Very often Sometimes Rarely  Never 
Member of the research team 20% (11) 39% (22) 20% (11) 9% (5) 11% (6) 
Doctor/health professional external to 
research team 
7% (4) 30% (17) 30% (17) 13% (7) 20% (11) 
External legal body (eg, guardianship 
tribunal) 
0 0 16% (9) 18% (10) 63% (35) 
In your research, how often have you sought consent from the following decision-makers for a person 
with dementia? % (n) 
Individual with formal legal authority for 
the person (eg, family member formally 
appointed as decision-maker) 
25% (14) 36% (20) 28% (15) 4% (2) 9% (5) 
Individual with informal responsibility  
for the person (eg, family or other carer) 
14% (8) 38% (21) 32% (18) 4% (2) 13% (7) 





Table 4: Consequences of the ethics review process (n=48) 
Which of the following have occurred as the result of the ethics review process of your research studies involving 
people with fluctuating or reduced capacity?  % (n) 
Inconsistent responses from ethics committees (eg, same or similar study had different outcomes)  50% (24) 
Improved protections for research participants 38% (18) 
Excessive delay of a project  29% (14) 
Helped me plan for future research 23% (11) 
Would not approve the study or required substantive changes to study design 15% (7) 
Had a negative impact on collaborations or relations with research partners 10% (5) 
Note: Respondents could select more than one item. Items with 5 or more responses are reported. 
